2013-2028 Report on Global Parkinson Disease Drug Market by Player, Region, Type, Application and Sales Channel

Published: Jul, 2019 | Pages: 115 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Parkinson Disease Drug market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Parkinson Disease Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Parkinson Disease Drug market.

Leading players of Parkinson Disease Drug including:

•	Merck
•	Akorn
•	GSK
•	Novartis
•	Boehringer Ingelheim
•	Teva Pharmaceutical
•	Abbvie
•	Kyowa Hakko Kirin Pharma
•	Astellas Pharma
•	Desitin Arzneimittel
•	Endo Pharmaceuticals
•	F.Hoffmann-La Roche
•	H.Lundbeck
•	Valeant
•	Apokyn
•	Orion
•	Stada Arzneimittel
•	US WorldMeds
•	Valeant Pharmaceuticals

Market split by Type, can be divided into:

•	Sinemet-CR
•	Trastal
•	Madopar
•	COMT Inhibitor
•	Other

Market split by Application, can be divided into:

•	Under 40 Years Old
•	40-65 Years Old
•	Above 65 Years Old

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Parkinson Disease Drug Market Overview
    1.1 Parkinson Disease Drug Definition
    1.2 Global Parkinson Disease Drug Market Size Status and Outlook (2013-2028)
    1.3 Global Parkinson Disease Drug Market Size Comparison by Region (2013-2028)
    1.4 Global Parkinson Disease Drug Market Size Comparison by Type (2013-2028)
    1.5 Global Parkinson Disease Drug Market Size Comparison by Application (2013-2028)
    1.6 Global Parkinson Disease Drug Market Size Comparison by Sales Channel (2013-2028)
    1.7 Parkinson Disease Drug Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Parkinson Disease Drug Market Segment Analysis by Player
    2.1 Global Parkinson Disease Drug Sales and Market Share by Player (2016-2018)
    2.2 Global Parkinson Disease Drug Revenue and Market Share by Player (2016-2018)
    2.3 Global Parkinson Disease Drug Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Parkinson Disease Drug Market Segment Analysis by Type
    3.1 Global Parkinson Disease Drug Market by Type
        3.1.1 Sinemet-CR
        3.1.2 Trastal
        3.1.3 Madopar
        3.1.4 COMT Inhibitor
        3.1.5 Other
    3.2 Global Parkinson Disease Drug Sales and Market Share by Type (2013-2018)
    3.3 Global Parkinson Disease Drug Revenue and Market Share by Type (2013-2018)
    3.4 Global Parkinson Disease Drug Average Price by Type (2013-2018)
    3.5 Leading Players of Parkinson Disease Drug by Type in 2018
    3.6 Conclusion of Segment by Type

Chapter 4 Parkinson Disease Drug Market Segment Analysis by Application
    4.1 Global Parkinson Disease Drug Market by Application
        4.1.1 Under 40 Years Old
        4.1.2 40-65 Years Old
        4.1.3 Above 65 Years Old
    4.2 Global Parkinson Disease Drug Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Parkinson Disease Drug by Application in 2018
    4.4 Conclusion of Segment by Application

Chapter 5 Parkinson Disease Drug Market Segment Analysis by Sales Channel
    5.1 Global Parkinson Disease Drug Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Parkinson Disease Drug Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Parkinson Disease Drug by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Parkinson Disease Drug Market Segment Analysis by Region
    6.1 Global Parkinson Disease Drug Market Size and CAGR by Region (2013-2028)
    6.2 Global Parkinson Disease Drug Sales and Market Share by Region (2013-2018)
    6.3 Global Parkinson Disease Drug Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Parkinson Disease Drug Market Share by Type
        6.4.3 North America Parkinson Disease Drug Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Parkinson Disease Drug Market Share by Type
        6.5.3 Europe Parkinson Disease Drug Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Parkinson Disease Drug Market Share by Type
        6.6.3 Asia-Pacific Parkinson Disease Drug Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Parkinson Disease Drug Market Share by Type
        6.7.3 South America Parkinson Disease Drug Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Parkinson Disease Drug Market Share by Type
        6.8.3 Middle East & Africa Parkinson Disease Drug Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Parkinson Disease Drug Players
    7.1 Merck
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Akorn
    7.3 GSK
    7.4 Novartis
    7.5 Boehringer Ingelheim
    7.6 Teva Pharmaceutical
    7.7 Abbvie
    7.8 Kyowa Hakko Kirin Pharma
    7.9 Astellas Pharma
    7.10 Desitin Arzneimittel
    7.11 Endo Pharmaceuticals
    7.12 F.Hoffmann-La Roche
    7.13 H.Lundbeck
    7.14 Valeant
    7.15 Apokyn
    7.16 Orion
    7.17 Stada Arzneimittel
    7.18 US WorldMeds
    7.19 Valeant Pharmaceuticals

Chapter 8 Upstream and Downstream Analysis of Parkinson Disease Drug
    8.1 Industrial Chain of Parkinson Disease Drug
    8.2 Upstream of Parkinson Disease Drug
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Parkinson Disease Drug
        8.3.1 Leading Distributors/Dealers of Parkinson Disease Drug
        8.3.2 Leading Consumers of Parkinson Disease Drug

Chapter 9 Development Trend of Parkinson Disease Drug (2019-2028)
    9.1 Global Parkinson Disease Drug Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Parkinson Disease Drug Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Parkinson Disease Drug Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Parkinson Disease Drug Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Parkinson Disease Drug Market Size Forecast by Sales Channel (2019-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Parkinson Disease Drug Example
    Figure Global Parkinson Disease Drug Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Parkinson Disease Drug Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Parkinson Disease Drug Sales Comparison by Type (2013-2028)
    Figure Global Parkinson Disease Drug Sales Comparison by Application (2013-2028)
    Figure Global Parkinson Disease Drug Sales Comparison by Sales Channel (2013-2028)
    Table Global Parkinson Disease Drug Sales by Player (2016-2018)
    Table Global Parkinson Disease Drug Sales Market Share by Player (2016-2018)
    Figure Global Parkinson Disease Drug Sales Market Share by Player in 2018
    Table Global Parkinson Disease Drug Revenue (Million $) by Player (2016-2018)
    Table Global Parkinson Disease Drug Revenue Market Share by Player (2016-2018)
    Figure Global Parkinson Disease Drug Revenue Market Share by Player in 2018
    Table Global Parkinson Disease Drug Average Price by Player (2016-2018)
    Figure Global Parkinson Disease Drug Average Price by Player in 2018
    Figure Global Parkinson Disease Drug Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Parkinson Disease Drug Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Sinemet-CR
    Figure Global Sinemet-CR Sales and Growth Rate (2013-2018)
    Figure Example of Trastal
    Figure Global Trastal Sales and Growth Rate (2013-2018)
    Figure Example of Madopar
    Figure Global Madopar Sales and Growth Rate (2013-2018)
    Figure Example of COMT Inhibitor
    Figure Global COMT Inhibitor Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Other Sales and Growth Rate (2013-2018)
    Table Global Parkinson Disease Drug Sales by Type (2013-2018)
    Table Global Parkinson Disease Drug Sales Market Share by Type (2013-2018)
    Figure Global Parkinson Disease Drug Sales Market Share by Type in 2018
    Table Global Parkinson Disease Drug Revenue (Million $) by Type (2013-2018)
    Table Global Parkinson Disease Drug Revenue Market Share by Type (2013-2018)
    Figure Global Parkinson Disease Drug Revenue Market Share by Type in 2018
    Table Global Parkinson Disease Drug Average Price by Type (2013-2018)
    Figure Global Parkinson Disease Drug Average Price by Type in 2018
    Table Leading Players of Parkinson Disease Drug by Type in 2018
    Figure Example of Under 40 Years Old
    Figure Global Parkinson Disease Drug for Under 40 Years Old Sales and Growth Rate (2013-2018)
    Figure Example of 40-65 Years Old
    Figure Global Parkinson Disease Drug for 40-65 Years Old Sales and Growth Rate (2013-2018)
    Figure Example of Above 65 Years Old
    Figure Global Parkinson Disease Drug for Above 65 Years Old Sales and Growth Rate (2013-2018)
    Table Global Parkinson Disease Drug Sales by Application (2013-2018)
    Table Global Parkinson Disease Drug Sales Market Share by Application (2013-2018)
    Figure Global Parkinson Disease Drug Sales Market Share by Application in 2018
    Table Leading Consumers of Parkinson Disease Drug by Application in 2018
    Figure Example of Direct Channel
    Figure Global Parkinson Disease Drug for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Parkinson Disease Drug for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Parkinson Disease Drug Sales by Sales Channel (2013-2018)
    Table Global Parkinson Disease Drug Sales Market Share by Sales Channel (2013-2018)
    Figure Global Parkinson Disease Drug Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Parkinson Disease Drug by Sales Channel in 2018
    Table Global Parkinson Disease Drug Market Size and CAGR by Region (2013-2028)
    Table Global Parkinson Disease Drug Sales by Region (2013-2018)
    Table Global Parkinson Disease Drug Sales Market Share by Region (2013-2018)
    Figure Global Parkinson Disease Drug Sales Market Share by Region in 2018
    Table Global Parkinson Disease Drug Revenue (Million $) by Region (2013-2018)
    Table Global Parkinson Disease Drug Revenue Market Share by Region (2013-2018)
    Figure Global Parkinson Disease Drug Revenue Market Share by Region in 2018
    Table North America Parkinson Disease Drug Sales by Country (2013-2018)
    Figure North America Parkinson Disease Drug Sales Market Share by Country (2013-2018)
    Table North America Parkinson Disease Drug Revenue by Country (2013-2018)
    Figure North America Parkinson Disease Drug Revenue Market Share by Country (2013-2018)
    Figure North America Parkinson Disease Drug Sales Market Share by Type in 2018
    Figure North America Parkinson Disease Drug Sales Market Share by Application in 2018
    Figure United States Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure United States Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Canada Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Mexico Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Parkinson Disease Drug Sales by Country (2013-2018)
    Figure Europe Parkinson Disease Drug Sales Market Share by Country (2013-2018)
    Table Europe Parkinson Disease Drug Revenue by Country (2013-2018)
    Figure Europe Parkinson Disease Drug Revenue Market Share by Country (2013-2018)
    Figure Europe Parkinson Disease Drug Sales Market Share by Type in 2018
    Figure Europe Parkinson Disease Drug Sales Market Share by Application in 2018
    Figure Germany Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Germany Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure UK Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure France Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Italy Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Russia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Spain Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Parkinson Disease Drug Sales by Country (2013-2018)
    Figure Asia-Pacific Parkinson Disease Drug Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Parkinson Disease Drug Revenue by Country (2013-2018)
    Figure Asia-Pacific Parkinson Disease Drug Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Parkinson Disease Drug Sales Market Share by Type in 2018
    Figure Asia-Pacific Parkinson Disease Drug Sales Market Share by Application in 2018
    Figure China Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure China Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Japan Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Korea Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure India Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Australia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Parkinson Disease Drug Sales by Country (2013-2018)
    Figure South America Parkinson Disease Drug Sales Market Share by Country (2013-2018)
    Table South America Parkinson Disease Drug Revenue by Country (2013-2018)
    Figure South America Parkinson Disease Drug Revenue Market Share by Country (2013-2018)
    Figure South America Parkinson Disease Drug Sales Market Share by Type in 2018
    Figure South America Parkinson Disease Drug Sales Market Share by Application in 2018
    Figure Brazil Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Brazil Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Argentina Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Colombia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Chile Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Parkinson Disease Drug Sales by Country (2013-2018)
    Figure Middle East & Africa Parkinson Disease Drug Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Parkinson Disease Drug Revenue by Country (2013-2018)
    Figure Middle East & Africa Parkinson Disease Drug Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Parkinson Disease Drug Sales Market Share by Type in 2018
    Figure Middle East & Africa Parkinson Disease Drug Sales Market Share by Application in 2018
    Figure Egypt Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Egypt Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure South Africa Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Parkinson Disease Drug Sales and Growth Rate (2013-2018)
    Figure Nigeria Parkinson Disease Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Merck
    Table Parkinson Disease Drug Introduction of Merck
    Table Parkinson Disease Drug Sales, Price, Revenue, Gross Margin and Market Share of Merck (2016-2018)
    Table Industrial Chain of Parkinson Disease Drug
    Table Manufacturing Cost Structure of Parkinson Disease Drug
    Table General Manufacturing Process of Parkinson Disease Drug
    Table Leading Distributors/Dealers of Parkinson Disease Drug
    Table Leading Consumers of Parkinson Disease Drug
    Figure Global Parkinson Disease Drug Sales and Growth Rate Forecast (2019-2028)
    Figure Global Parkinson Disease Drug Revenue and Growth Rate Forecast (2019-2028)
    Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Sales Channel (2019-2028)